CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Clinical trial NCT04718883 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04718883
- Sponsor
- Shanghai Ming Ju Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2023-10-25
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.